MPWT
ITCI

MassMutual Private Wealth & Trust’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-240
Closed -$31.7K – 2521
2025
Q1 		$31.7K Buy
240
+133
+124% +$16.6K ﹤0.01% 861
2024
Q4 		$8.94K Buy
107
+55
+106% +$4.52K ﹤0.01% 1301
2024
Q3 		$3.81K Hold
52
– – ﹤0.01% 1464
2024
Q2 		$3.56K Buy
52
+5
+11% +$347 ﹤0.01% 1436
2024
Q1 		$3.25K Buy
47
+2
+4% +$137 ﹤0.01% 1397
2023
Q4 		$3.22K Sell
45
-11
-20% -$633 ﹤0.01% 1362
2023
Q3 		$2.92K Buy
56
+13
+30% +$757 ﹤0.01% 1395
2023
Q2 		$2.72K Hold
43
– – ﹤0.01% 1382
2023
Q1 		$2.33K Hold
43
– – ﹤0.01% 1377
2022
Q4 		$2K Hold
43
– – ﹤0.01% 1357
2022
Q3 		$2K Buy
43
+11
+34% +$575 ﹤0.01% 1316
2022
Q2 		$2K Hold
32
– – ﹤0.01% 1225
2022
Q1 		$2K Buy
32
+20
+167% +$1.04K ﹤0.01% 1222
2021
Q4 		$1K Buy
+12
New +$504 ﹤0.01% 1345

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MassMutual Private Wealth & Trust's ITCI Position: Q2 2025 in Review

MassMutual Private Wealth & Trust sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 240 shares — an estimated $31.7K sold.

MassMutual Private Wealth & Trust first reported a position in ITCI in Q4 2021 and held it in 14 quarters. The position peaked at $31.7K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • MassMutual Private Wealth & Trust reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 240 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $31.7K.
  • MassMutual Private Wealth & Trust first reported a position in Intra-Cellular Therapies Inc. in Q4 2021 and held it in 14 quarters.
  • MassMutual Private Wealth & Trust's Intra-Cellular Therapies Inc. position peaked at $31.7K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2025, filed 9 Jul 2025.